Oak Therapeutics | Top Oral Dissolvable Strip Technology Solutions 202
Pharma Tech Outlook

Pharma Tech Outlook

Oak Therapeutics
Expanding Drug Access through High-Load Oral Dissolvable Strip Innovation

Oak Therapeutics: Expanding Drug Access through High-Load Oral Dissolvable Strip Innovation

Drug delivery continues to face a critical challenge in making medicines usable for patients who struggle with traditional formats. Tablets and liquids often fail populations such as children, the elderly and individuals with swallowing or neuromotor difficulties, creating barriers to effective treatment.

Oak Therapeutics addresses this gap by focusing on usability as a primary design principle. Its oral dissolvable strip technology is engineered to remove barriers such as swallowing difficulty, refrigeration and complex preparation.

“At Oak, we start from the opposite premise: no one should be left behind in healthcare, regardless of geography, culture, cost or local policy environment,” says Gerhard Apfelthaler, founding partner.

Designing for Real-World Accessibility

A central issue in drug delivery is the gap between what is technically available and what patients can realistically use. Many treatments require water, refrigeration or precise preparation, making them impractical in certain environments.

Oak Therapeutics addresses this by developing thin, portable strips that dissolve in the oral cavity without water. These strips embed full therapeutic doses and can be engineered to dissolve within seconds or over extended periods, depending on treatment needs.

This approach reduces caregiver burden and minimizes dosing errors, while improving adherence across diverse patient groups. By focusing on acceptability and simplicity, the company ensures that treatments fit into real-world conditions.

Its framework considers factors such as taste, cultural fit, and ease of administration, ensuring that each product aligns with patient and caregiver needs across different settings.

Scaling High-Dose Delivery through Platform Innovation

Another limitation in traditional strip technology has been low drug capacity, restricting its use to niche applications. This constraint has limited the broader adoption of oral dissolvable strips for higher-dose treatments.

Oak Therapeutics has addressed this by increasing the proportion of active ingredient within each strip while maintaining structural integrity and safety. This advancement enables the delivery of higher-dose therapies for conditions such as infectious diseases and pain management.

  • At Oak, we start from the opposite premise: no one should be left behind in healthcare, regardless of geography, culture, cost or local policy environment.


To support scalability, the company has developed a platform-based approach that allows new drugs to be integrated into a validated strip architecture. Continuous manufacturing processes enable production to scale efficiently from small clinical batches to large volumes.

This combination of high drug load and scalable production expands the potential of oral strips beyond specialized use cases into broader therapeutic applications.

Demonstrating Impact in Complex Treatment Environments

The company’s approach is demonstrated in its work on tuberculosis treatment. Traditional delivery methods can be difficult for patients who require long-term therapy and struggle with standard dosage forms.

Oak Therapeutics developed a high-load strip capable of delivering a full therapeutic dose while maintaining predictable dissolution and safety. The solution was designed to integrate into existing treatment workflows without requiring significant changes to clinical practices.

The results included achieving pharmacokinetic profiles comparable to conventional dosage forms while improving usability. The strip format eliminated the need for water and simplified administration, making it suitable for both clinical and low-resource environments.

This example highlights how the platform can improve treatment adherence and extend access to essential medicines.

Looking ahead, drug delivery is moving toward formats that combine flexibility, scalability and patient-centered design. Increasing demand for personalized treatment and platform-based solutions is shaping the development of new technologies.

Oak Therapeutics is positioning itself within this shift by integrating data-driven methods into its development process. Tools such as machine learning and modeling approaches are used to optimize formulation and accelerate development timelines.

By combining high-capacity strip technology, scalable manufacturing and data-informed design, the company enables broader access to medicines while maintaining practical usability.

Deep Dive

Advancing Drug Access through Oral Dissolvable Strip Technology

Pharmaceutical leaders evaluating oral dissolvable strip technology face a harder question than whether the dosage form is convenient. The real issue is whether the solution can carry clinically meaningful therapies while making medication easier for patients who are poorly served by tablets, capsules and liquid formulations. Children, older adults, patients with neurological or developmental challenges and people receiving care in low-resource settings often encounter barriers that turn a prescribed therapy into an impractical routine. Water may not be available at the right time. Refrigeration may be unreliable. Liquid dosing may create measurement errors. Tablets may be difficult or impossible to swallow. For executives, these are not minor usability issues; they influence adherence, access, safety and the economic performance of a therapy across its lifecycle. A gold-standard solution begins by treating patient acceptability as a design requirement rather than a latestage adjustment. Strips must dissolve predictably in the oral cavity, require no complex preparation and reduce the burden on caregivers. Palatability, texture, portability and ease of administration matter because a formulation that performs in the lab can still fail if patients resist using it. This is especially important in pediatric, geriatric and chronic-care environments, where treatment may continue for months and the person administering the medicine may not be a clinician. The strongest technologies make the dose feel simple without weakening the discipline behind formulation, stability and release behavior. Load capacity is equally central. Traditional strip formats have often been limited by the amount of active ingredient they can carry, which has confined them to narrow use cases or lower-dose applications. Pharmaceutical buyers should look for technology that can accommodate a full therapeutic dose while preserving strip integrity, safety, uniformity and predictable dissolution. Without that balance, the format risks becoming a convenience feature rather than a serious delivery platform. Higher-load performance expands the addressable therapeutic range, including infectious disease, pain management and other areas where dose size has historically made strip delivery difficult. “Oak Therapeutics’s tuberculosis work shows how the technology can match conventional pharmacokinetic expectations while improving administration for clinical and low-resource settings.” Scalability completes the assessment. A promising formulation has limited value if it cannot move from feasibility work to clinical quantities and commercial supply. The preferred model should allow new drugs to enter a validated platform architecture, shorten development cycles and support production without excessive rework. It should also allow release timing to be tailored, since some therapies require rapid dissolution while others may benefit from slower exposure. Data-informed formulation work, controlled manufacturing and practical integration into existing care workflows all reduce the risk that an attractive technology stalls before broad use. The strongest engagements also demand regulatory awareness, early manufacturability testing and evidence that the format can fit prescribing habits, packaging requirements and distribution constraints without creating fresh friction at scale. Oak Therapeutics stands out as a premier choice because its work aligns closely with these demands. It focuses on oral dissolvable strips that dissolve without water, support full-dose delivery and can be tuned from rapid release to dissolution over multiple hours. Its platform is built around high activeingredient loading, including more than 350 mg on a thin strip, custom dosing and scalable production methods. Its tuberculosis work shows how the technology can match conventional pharmacokinetic expectations while improving administration for clinical and low-resource settings. For pharma executives looking for a gold-standard strip platform, Oak Therapeutics merits serious consideration. ...Read more

Oral Dissolvable Strip Technology Solutions Info

Q1

What Are Oral Dissolvable Strip Technology Solutions?

Oral Dissolvable Strip Technology Solutions are drug delivery platforms that place active ingredients in thin films designed to dissolve on the tongue or inside the cheek. They can offer an alternative to tablets, capsules and liquids, particularly when swallowing, portability or discreet administration presents a challenge. The category covers formulation design, dose loading, release control, strip stability and manufacturing processes that help translate medicines into a convenient oral format.

Q2

How Does Oak Therapeutics Apply Dissolvable Strip Technology?

Oak Therapeutics uses its proprietary technology, known as Oral Dissolvable Strip Technology Solutions, delivered by a unique platform designed to enable higher drug loading and variability in release profile. Its strips are only the size of a stamp but can contain over 350 mg of the active pharmaceutical ingredient, and formulations can be created that dissolve in seconds or can be sustained over a longer period of time. This flexibility allows for the possibility of developing a wider variety of compounds for use as a strip-based drug delivery system, such as drugs that need to be given in large doses or for controlled release.

Q3

What Problems Can Oral Dissolvable Strip Technology Solutions Address?

Oral Dissolvable Strip Technology Solutions can address practical barriers associated with conventional dosage forms. A strip that dissolves without water may be easier to use for people who struggle with tablets or capsules. The format can also support portable, discreet dosing and reduce the handling demands associated with liquid medicines. Depending on formulation design, oral dissolvable strips may improve dose flexibility, administration convenience and continuity for users whose needs are not well served by fixed solid doses.

Q4

Which Technical Factors Matter When Evaluating Dissolvable Strips?

Important factors include drug-loading capacity, ingredient uniformity, dissolution timing, taste, stability and the intended absorption site. Oral Dissolvable Strip Technology Solutions must balance these considerations without making the strip difficult to handle or administer. Developers should also assess whether the formulation supports rapid action, controlled release or another clinically appropriate profile. Manufacturing scalability and consistency are equally important because reliable performance must be maintained as production moves beyond laboratory development.

Q5

How Does Oak Therapeutics Support Flexible Dosing and Manufacturing?

Oak Therapeutics uses Oral Dissolvable Strip Technology Solutions to support dose customization through the homogeneous distribution of active ingredients across each strip. The strips can be divided into fractional pieces, allowing dose adjustments based on considerations such as age or body weight. The company is also exploring cold extrusion and other manufacturing methods intended to reduce the energy use and material waste associated with traditional strip production. Its development pipeline spans nutraceutical, over-the-counter and prescription applications.

Q6

What Value Can Strip-Based Drug Delivery Create?

Oral Dissolvable Strip Technology Solutions can create value by connecting pharmaceutical performance with practical usability. A well-designed strip may simplify administration, avoid the need for water and provide release characteristics suited to a particular medicine. It may also give formulation teams another route for products that require higher loading or more flexible dosing. The strongest programs align patient use, ingredient behavior, manufacturing repeatability and regulatory expectations rather than treating the dosage form as a convenience feature alone. That alignment helps determine whether the format can deliver dependable value in routine use.

Top Oral Dissolvable Strip Technology Solutions 2026

Company
Oak Therapeutics

Management
Gerhard Apfelthaler, Founding Partner

Description
Oak Therapeutics develops oral dissolvable strip technology for drug delivery, enabling high-dose, patient-friendly formulations. Its platform focuses on accessibility, scalability, and usability, supporting pharmaceutical partners in delivering effective treatments across diverse populations and real-world healthcare environments.